News

Merck acquires Raleigh pharma for $10 billion
The enormous deal comes as the Raleigh company's market cap has ballooned to several billion dollars. Destination Triangle: ...
NJBIZ1d
Merck to acquire Verona Pharma in $10B COPD drug deal
Merck is expanding its pipeline and portfolio of cardio-pulmonary disease treatments by acquiring Verona Pharma plc.
InvestorsHub on MSN2d
Merck to Acquire Verona Pharma in $10 Billion Deal to Expand Respiratory Drug Portfolio
Merck (NYSE:MRK) announced Wednesday it has struck a definitive agreement to acquire Verona Pharma PLC ADR (NASDAQ:VRNA) in a transaction valued at approximately $10 billion, or $107 per American ...